Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Education | $7,103 | 6 | 82.0% |
| Food and Beverage | $1,067 | 56 | 12.3% |
| Travel and Lodging | $494.84 | 4 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $7,557 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $209.53 | 13 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $152.43 | 10 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $89.00 | 1 | $0 (2022) |
| Ethicon Inc. | $83.41 | 1 | $0 (2022) |
| Genentech USA, Inc. | $73.43 | 3 | $0 (2024) |
| United Therapeutics Corporation | $50.63 | 2 | $0 (2024) |
| Grifols USA, LLC | $45.69 | 2 | $0 (2023) |
| Bayer HealthCare Pharmaceuticals Inc. | $41.61 | 3 | $0 (2017) |
| Philips Electronics North America Corporation | $37.44 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,647 | 17 | INTUITIVE SURGICAL, INC. ($7,495) |
| 2023 | $227.24 | 9 | GlaxoSmithKline, LLC. ($40.04) |
| 2022 | $315.59 | 8 | SANOFI-AVENTIS U.S. LLC ($89.00) |
| 2021 | $27.87 | 2 | GlaxoSmithKline, LLC. ($15.91) |
| 2020 | $37.01 | 3 | GlaxoSmithKline, LLC. ($25.93) |
| 2017 | $409.69 | 27 | Boehringer Ingelheim Pharmaceuticals, Inc. ($152.43) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: Immunology | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 09/13/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 09/11/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 09/06/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $1,500.00 | General |
| Category: SURGERY | ||||||
| 09/05/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $241.42 | General |
| Category: SURGERY | ||||||
| 09/05/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $241.42 | General |
| Category: SURGERY | ||||||
| 08/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $2,500.00 | General |
| Category: SURGERY | ||||||
| 08/28/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 08/13/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Travel and Lodging | In-kind items and services | $6.00 | General |
| Category: SURGERY | ||||||
| 07/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Immunology | ||||||
| 06/20/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $7.04 | General |
| Category: Sleep Apnea testing | ||||||
| 04/09/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Respiratory | ||||||
| 04/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: RESPIRATORY | ||||||
| 03/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Immunology | ||||||
| 11/21/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $30.41 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/17/2023 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Immunology | ||||||
| 10/11/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $34.20 | General |
| Category: PAH | ||||||
| 10/10/2023 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $26.37 | General |
| 09/12/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $30.23 | General |
| Category: Inflammation | ||||||
| 08/15/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Respiratory | ||||||
| 06/12/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA, SHINGRIX | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 2,898 | 4,113 | $836,155 | $323,170 |
| 2022 | 22 | 2,600 | 3,789 | $784,650 | $294,767 |
| 2021 | 20 | 2,518 | 3,581 | $796,180 | $307,297 |
| 2020 | 20 | 1,622 | 2,711 | $684,125 | $246,628 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 416 | 600 | $150,000 | $54,874 | 36.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 385 | 409 | $163,600 | $53,988 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 316 | 555 | $83,250 | $52,409 | 63.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 372 | 843 | $168,600 | $50,736 | 30.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 80 | 171 | $85,500 | $28,157 | 32.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 141 | 211 | $42,200 | $27,550 | 65.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 88 | 88 | $21,120 | $10,903 | 51.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 58 | 58 | $17,980 | $9,093 | 50.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 174 | 199 | $16,915 | $8,457 | 50.0% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 172 | 197 | $13,790 | $6,465 | 46.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 174 | 199 | $18,905 | $5,746 | 30.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 42 | $4,200 | $2,730 | 65.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 12 | 12 | $5,675 | $2,557 | 45.1% |
| 94664 | Evaluation of use of breathing device | Office | 2023 | 174 | 199 | $4,975 | $2,542 | 51.1% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 43 | 45 | $18,000 | $2,425 | 13.5% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2023 | 173 | 199 | $5,970 | $1,343 | 22.5% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 20 | 20 | $2,400 | $1,165 | 48.5% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 11 | 11 | $4,675 | $1,121 | 24.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 31 | 36 | $2,700 | $908.95 | 33.7% |
| 31623 | Exam of lung airways using an endoscope | Facility | 2023 | 18 | 19 | $5,700 | $0.64 | 0.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 348 | 369 | $147,600 | $56,185 | 38.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 430 | 1,002 | $200,310 | $55,138 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 261 | 461 | $69,150 | $43,168 | 62.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 356 | 527 | $131,750 | $41,715 | 31.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 76 | 165 | $82,500 | $27,879 | 33.8% |
About Dr. Mhd-Iyad Saadi, MD
Dr. Mhd-Iyad Saadi, MD is a Pulmonary Disease healthcare provider based in Chandler, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/06/2009. The National Provider Identifier (NPI) number assigned to this provider is 1861621336.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mhd-Iyad Saadi, MD has received a total of $8,665 in payments from pharmaceutical and medical device companies, with $7,647 received in 2024. These payments were reported across 66 transactions from 26 companies. The most common payment nature is "Education" ($7,103).
As a Medicare-enrolled provider, Saadi has provided services to 9,638 Medicare beneficiaries, totaling 14,194 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine, Sleep Medicine
- Location Chandler, AZ
- Active Since 07/06/2009
- Last Updated 10/01/2025
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1861621336
Products in Payments
- Da Vinci Surgical System (Device) $7,557
- STIOLTO (Drug) $135.52
- DUPIXENT (Biological) $128.93
- Monarch Platform (Device) $83.41
- AREXVY (Drug) $74.45
- Xolair (Biological) $53.65
- TRELEGY ELLIPTA (Drug) $53.30
- TYVASO (Drug) $50.63
- Adempas (Drug) $41.61
- ANORO (Drug) $39.09
- (8685) OEM Other (Device) $37.44
- XARELTO (Drug) $30.41
- TEZSPIRE (Biological) $30.23
- CHANTIX (Drug) $24.03
- Xembify (Biological) $22.94
- Prolastin-C Liquid (Biological) $22.75
- Arikayce (Drug) $20.13
- Esbriet (Biological) $19.78
- BROVANA (Drug) $18.68
- BREO (Drug) $18.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Chandler
Muhammad Salim, Md, MD
Pulmonary Disease — Payments: $11,684
Loreto Sulit, Md, MD
Pulmonary Disease — Payments: $6,730
Mr. Salman Sheikh, Md, MD
Pulmonary Disease — Payments: $1,295
Pedro Quiroga, Md, MD
Pulmonary Disease — Payments: $732.94
Cesar Munoz, M.d, M.D
Pulmonary Disease — Payments: $254.68
Dr. Daniel Belen, Do, DO
Pulmonary Disease — Payments: $238.83